Gene expression profiling of epithelial ovarian tumours correlated with malignant potential

Molecular Cancer

Volumn 3, Issue , 2004, Pages

  Warrenfeltz, Susanne ^a,b   Pavlik, Stephen ^c   Datta, Susmita ^d   Kraemer, Eileen T ^b,c   Benigno, Benedict ^b   McDonald, John F ^a,b  

^a University of Georgia ^*  (United States)

^b Ovarian Cancer Institute   (United States)

^c Georgia State University ^*  (United States)

^d GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CELL ADHESION MOLECULE; SOMATOMEDIN BINDING PROTEIN;

ADENOCARCINOMA; ADENOMA; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CHEMOTHERAPY; CLUSTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC KIT; DISEASE CLASSIFICATION; EPITHELIUM TUMOR; FEMALE; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION PROFILING; GENE LOCATION; GENE OVEREXPRESSION; GENETIC EPIGENESIS; GENETIC LINKAGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; OVARY TUMOR; PREDICTION; PROTEIN FUNCTION; STATISTICAL ANALYSIS; TUMOR RECURRENCE; DNA MICROARRAY; EPITHELIUM CELL; GENETICS; METABOLISM; MULTIGENE FAMILY; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CLUSTER ANALYSIS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MULTIGENE FAMILY; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 13644263662     PISSN: 14764598     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-4598-3-27     Document Type: Article

References (49)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ: Cancer statistics. CA Cancer J Clin 2004, 54:8-29.
2. Schwartz PE: Current diagnosis and treatment modalities for ovarian cancer. Cancer Treat Res 2002, 107:99-118.
3. Ciro M, Bracken AP, Helin K: Profiling cancer. Curr Opin Cell Biol 2003, 15:213-220.
4. Adib TR, Henderson S, Perrett C, Hewitt D, Bourmpoulia D, Ledermann J, Boshoff C: Predicting biomarkers for ovarian cancer using gene-expression microarrays. Br J Cancer 2004, 90:686-692.
5. Jazaeri AA, Lu K, Schmandt R, Harris CP, Rao PH, Sotiriou C, Chandramouli GV, Gershenson DM, Liu ET: Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma. Mol Carcinog 2003, 36:53-59.
6. Lancaster JM, Dressman HK, Whitaker RS, Havrilesky L, Gray J, Marks JR, Nevins JR, Berchuck A: Gene expression patterns that characterize advanced stage serous ovarian cancers. J Soc Gynecol Investig 2004, 11:51-59.
7. Matei D, Graeber TG, Baldwin RL, Karlan BY, Rao J, Chang DD: Gene expression in epithelial ovarian carcinoma. Oncogene 2002, 21:6289-6298.
8. Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, Diehn M, Wang YC, Duran GE, Sikic TL, Caldeira S, Skomedal H, Tu IP, Hernandez-Boussard T, Johnson SW, O'Dwyer PJ, Fero MJ, Kristensen GB, Borresen-Dale AL, Hastie T, Tibshirani R, van de Rijn M, Teng NN, Longacre TA, Botstein D, Brown PO, Sikic BI: Gene expression patterns in ovarian carcinomas. Mol Biol Cell 2003, 14:4376-4386.
9. Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, Taylor JM, Misek DE, Wu R, Zhai Y, Darrah DM, Reed H, Ellenson LH, Giordano TJ, Fearon ER, Hanash SM, Cho KR: Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res 2002, 62:4722-4729.
10. Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA, Hampton GM: Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci U S A 2001, 98:1176-1181.
11. Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E, Lander ES, Golub TR: Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci U S A 1999, 96:2907-2912.
12. Tammela J, Lele S: New modalities in detection of recurrent ovarian cancer. Curr Opin Obstet Gynecol 2004, 16: -9.
13. Vaidya AP, Curtin JP: The follow-up of ovarian cancer. Semin Oncol 2003, 30:401-412.
14. Ott Lyman, Longnecker Michael: An Introduction to statistical methods and data analysis. 5th edition. Thomson Learning; 2001:1152.
15. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
16. Hosack DA, Dennis G., Jr., Sherman BT, Lane HC, Lempicki RA: Identifying biological themes within lists of genes with EASE. Genome Biol 2003, 4:R70.
17. Draghici S, Khatri P, Martins RP, Ostermeier GC, Krawetz SA: Global functional profiling of gene expression. Genomics 2003, 81:98-104.
18. Su AI, Welsh JB, Sapinoso LM, Kern SG, Dimitrov P, Lapp H, Schultz PG, Powell SM, Moskaluk CA, Frierson H. F., Jr., Hampton GM: Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 2001, 61:7388-7393.
19. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286: 31-537.
20. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, Cheng C, Campana D, Wilkins D, Zhou X, Li J, Liu H, Pui CH, Evans WE, Naeve C, Wong L, Downing JR: Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002, 1:133-143.
21. Hauptmann S, Dietel M: Serous tumors of low malignant potential of the ovary-molecular pathology: part 2. Virchows Arch 2001, 438:539-551.
22. Seidman JD, Ronnett BM, Kurman RJ: Pathology of borderline (low malignant potential) ovarian tumours. Best Pract Res Clin Obstet Gynaecol 2002, 16:499-512.
23. Crispens MA: Borderline ovarian tumours: a review of the recent literature. Curr Opin Obstet Gynecol 2003, 15: 9-43.
24. Dietel M, Hauptmann S: Serous tumors of low malignant potential of the ovary. 1. Diagnostic pathology. Virchows Arch 2000, 436:403-412.
25. Chin JL, Reiter RE: Genetic alterations in prostate cancer. Curr Urol Rep 2004, 5:157-165.
26. Hogdall EV, Ryan A, Kjaer SK, Blaakaer J, Christensen L, Bock JE, Glud E, Jacobs IJ, Hogdall CK: Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma. Cancer 2004, 100:2387-2395.
27. Santarosa M, Ashworth A: Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way. Biochim Biophys Acta 2004, 1654:105-122.
28. El-Osta A: The rise and fall of genomic methylation in cancer. Leukemia 2004, 18:233-237.
29. Esteller M: Cancer epigenetics: DNA methylation and chromatin alterations in human cancer. Adv Exp Med Biol 2003, 532:39-49.
30. Herman JG, Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003, 349:2042-2054.
31. Esteller M: CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002, 21:5427-5440.
32. Jain PK: Epigenetics: the role of methylation in the mechanism of action of tumor suppressor genes. Ann N Y Acad Sci 2003, 983:71-83.
33. Andersson A, Johansson B, Lassen C, Mitelman F, Billstrom R, Fioretos T: Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients. Eur J Haematol 2004, 72:307-313.
34. Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, Pruntel R, Regnerus R, van Welsem T, van Spaendonk R, Menko FH, Kluijt I, Dommering C, Verhoef S, Schouten JP, van't Veer LJ, Pals G: Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 2003, 63:1449-1453.
35. Lucito R, Healy J, Alexander J, Reiner A, Esposito D, Chi M, Rodgers L, Brady A, Sebat J, Troge J, West JA, Rostan S, Nguyen KC, Powers S, Ye KQ, Olshen A, Venkatraman E, Norton L, Wigler M: Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Res 2003, 13:2291-2305.
36. Menendez L, Benigno BB, McDonald JF: L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas. Mol Cancer 2004, 3:12.
37. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000, 100:57-70.
38. LeRoith D, Roberts C. T., Jr.: The insulin-like growth factor system and cancer. Cancer Lett 2003, 195:127-137.
39. Mauro L, Salerno M, Morelli C, Boterberg T, Bracke ME, Surmacz E: Role of the IGF-I receptor in the regulation of cell-cell adhesion: implications in cancer development and progression. J Cell Physiol 2003, 194:108-116.
40. Moschos SJ, Mantzoros CS: The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 2002, 63:317-332.
41. Baron-Hay S, Boyle F, Ferrier A, Scott C: Elevated serum insulin-like growth factor binding protein-2 as a prognostic marker in patients with ovarian cancer. Clin Cancer Res 2004, 10: 796-1806.
42. Lukanova A, Lundin E, Toniolo P, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V, Zeleniuch-Jacquotte A, Berrino F, Hallmans G, Riboli E, Kaaks R: Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int J Cancer 2002, 101:549-554.
43. Surmacz E, Guvakova MA, Nolan MK, Nicosia RF, Sciacca L: Type I insulin-like growth factor receptor function in breast cancer. Breast Cancer Res Treat 1998, 47:255-267.
44. Sundfeldt K: Cell-cell adhesion in the normal ovary and ovarian tumors of epithelial origin; an exception to the rule. Mol Cell Endocrinol 2003, 202:89-96.
45. Hazan RB, Qiao R, Keren R, Badano I, Suyama K: Cadherin switch in tumor progression. Ann N Y Acad Sci 2004, 1014: 55-163.
46. Patel IS, Madan P, Getsios S, Bertrand MA, MacCalman CD: Cadherin switching in ovarian cancer progression. Int J Cancer 2003, 106:172-177.
47. Goodman MT, Wu AH, Tung KH, McDuffie K, Kolonel LN, Nomura AM, Terada K, Wilkens LR, Murphy S, Hankin JH: Association of dairy products, lactose, and calcium with the risk of ovarian cancer. Am J Epidemiol 2002, 156:148-157.
48. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP: Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003, 31:e15.
49. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.